Insider · CIK 0002035345
Edmundson Tina Edekar
Files at MLKN (MILLERKNOLL, INC.). First filing -, latest -.
In brief
Edmundson Tina Edekar files SEC Form 4 as director at MLKN (MILLERKNOLL, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Edmundson Tina Edekar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | MLKN MILLERKNOLL, INC. | AGrant or award Common Stock | +6,153 | $19.50 | $120k | 11,632 | Jan 16, 2026 |
| Jan 15, 2026 | MLKN MILLERKNOLL, INC. | MOption exercise Common Stock | +616 | $19.50 | $12k | 12,248 | Jan 16, 2026 |
| Jan 15, 2026 | MLKN MILLERKNOLL, INC. | MOption exercise Phantom Stockderivative | -616 | $19.50 | $12k | 1,231 | Jan 16, 2026 |
| Jan 15, 2025 | MLKN MILLERKNOLL, INC. | AGrant or award Common Stock | +5,479 | $21.90 | $120k | 5,479 | Jan 17, 2025 |
Questions about Edmundson Tina Edekar
Answered from the filings on this page, as of the latest one.
Is Edmundson Tina Edekar buying or selling?
Edmundson Tina Edekar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Edmundson Tina Edekar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edmundson Tina Edekar has 0.
Where does Edmundson Tina Edekar file Form 4?
Edmundson Tina Edekar has filed Form 4 at MLKN (MILLERKNOLL, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.